An immunohistochemical study of the effects of various antioxidants on rat lung during chemotherapy

References

• Batist G, Andrews JL (1981). Pulmonary toxicity of antineoplastic drugs. J Am Med Assoc. 246:1449–1453.
   PubMed Web of Science ®Google Scholar
• Buyukbayram H, Cureoglu S, Arslan A, Işikakdogan AR (2004) Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma. Cancer Invest. 22:195–202.
   PubMed Web of Science ®Google Scholar
• Carmel RJ, Brown JM (1977) The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice. Cancer Res. 37:145–51.
   PubMed Web of Science ®Google Scholar
• Chen FP, Gong LK, Zhang L, Wang H, Qi XM, Wu XF, Xiao Y, Cai Y, Liu LL, Li XH, Ren J (2007) Early lung injury contributes to lung fibrosis via AT1, receptor in rats. Acta Pharm Col Sin. 28:227–237.
   PubMed Web of Science ®Google Scholar
• Choong PF, Akerman M, Willen H, Anderson C, Gustafson P, Alvegard T, Rydholm A (1995) Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in soft tissue sarcoma. Is prognostic significance histotype‐specific? APMIS. 103:797–805.
   PubMed Web of Science ®Google Scholar
• Ciencewicki J, Trivedi S, Kleeberger SR (2008) Oxidants and the pathogenesis of lung diseases. J Aller Clin Immunol. 122:456–470.
   PubMed Web of Science ®Google Scholar
• Constantini P, Jacotot E, Decaudin D, Kroemer G (2000) Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst. 92:1042–1053.
   PubMedGoogle Scholar
• Critchfield JW, Dubick M, Last J, Cross CE, Rucker RB (1985) Changes in response to ascorbic acid administered orally to rat pups: lung collagen, elastin and protein synthesis. J Nutr. 115:70–77.
   PubMed Web of Science ®Google Scholar
• Dias MF, Sousa E, Cabrita S, Patrício J, Oliveira CF (2000) Chemoprevention of DMBA-induced mammary tumors in rats by a combined regimen of alpha-tocopherol, selenium, and ascorbic acid. Breast J. 6:14–19.
   PubMedGoogle Scholar
• Dunn SE, Hardman RA, Kari FW, Barret JC (1997) Insulin-like growth factor-1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 57:2687–2693.
   PubMed Web of Science ®Google Scholar
• Erdoğan BB, Uzaslan EK (2003) Apoptosis mechanism: Fas-FasL-mediated apoptosis in tumour development. Turk Clin Arch Lung. 4:165–174.
   Google Scholar
• Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V (2012) Role of apoptosis in disease. Aging. 4:330–349.
   PubMedGoogle Scholar
• Geiser T (2003) Idiopathic pulmonary fibrosis─a disorder of alveolar wound repair? Swiss Med Wkly. 133:405–411.
   PubMed Web of Science ®Google Scholar
• Gurgen SG, Erdoğan D, Elmas C, Kaplanoglu GT, Ozer C (2013) Chemoprotective effect of ascorbic acid, α-tocopherol, and selenium on cyclophosphamide-induced toxicity in the rat ovarium. Nutrition. 29:777–784.
   PubMed Web of Science ®Google Scholar
• Kumar RK, Truscoll JY, Rhodes GC, Lykke AWJ (1988) Type 2 pneumocyte responses to cyclophosphamide-induced pulmonary injury: functional and morphological correlation. Br J Exp Pathol. 69:69–80.
   PubMedGoogle Scholar
• Macconi D, Remuzzi G, Benigni A (2014) Key fibrogenic mediators: old players. Renin-angiotensin system. Kidney Int Suppl. 4:58–64.
   Web of Science ®Google Scholar
• Marshall RP (2003) The pulmonary renin-angiotensin system. Curr Pharm Des. 9:715–22.
   PubMed Web of Science ®Google Scholar
• Messent M, Sinclair DG, Quinlan GJ, Mumby SE, Gutteridge JM, Evans TW (1997) Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Cor Med. 25:425–429.
   PubMed Web of Science ®Google Scholar
• Mu XD, Bellayr IH, Walters TJ, Li Y (2010) Mediators leading to fibrosis─ how to measure and control them in tissue engineering. Oper Tech Orthop. 20:110–118.
   PubMedGoogle Scholar
• Muralikrishnan G, Amalan SV, Sadasivan PK (2001) Dual role of vitamin C on lipid profile and combined application of cyclophosphamide, methotrexate and 5-fluorouracil treatment in fibrosarcoma-bearing rats. Cancer Lett. 169:115–120.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S (2004) Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax. 59:31–8.
   PubMed Web of Science ®Google Scholar
• Papp M, Li X, Zhuang J, Wang R, Uhal BD (2002) Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol. 282:713–718.
   Web of Science ®Google Scholar
• Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim HC, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH (2009) Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet. 15:1963–1971.
   Google Scholar
• Patel JM (1990) Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther. 47:137–146.
   PubMed Web of Science ®Google Scholar
• Pouzet MT, Travis EL (1992) No change in repair capacity of mouse lung irradiated three months after a single dose of cyclophosphamide. Cancer Res. 52:1096–1100.
   PubMed Web of Science ®Google Scholar
• Reid ME, Duffield-Lillico AJ, Sunga A (2006) Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer. 118:1777–1781
   PubMed Web of Science ®Google Scholar
• Rubin P, Siemann DW, Shapiro DL, Finkelstein JN, Penney DP (1983) Surfactant release as an early measure of radiation pneumonitis. Int J Rad Oncol Biol Phys. 9:1669–1673.
   PubMed Web of Science ®Google Scholar
• Rüster C, Wolf G (2011) Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol. 22:1189–1199.
   PubMed Web of Science ®Google Scholar
• Rodrigues da Silva M, Schapochnik A, Leal MP, Esteves J, Hebeda CB, Sandri S, Pavani C, Ratto AC, Horliana T, Farsky SHP, Lino-dos-Santos-Franco A (2018) Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat. PLoS ONE 13(11): e0205535. https://doi.org/10.1371/journal. pone.0205535
   PubMed Web of Science ®Google Scholar
• Schmidt R, Luboeinski T, Markart P, Ruppert C, Daum C, Grimminger F, Seeger W, Günther A (2004) Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur Resp J. 24:994–999.
   PubMed Web of Science ®Google Scholar
• Smith RD, Kehrer JP (1991) Co-oxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. Cancer Res. 51:542–548.
   PubMed Web of Science ®Google Scholar
• Tanel A, Averill-Bates DA (2007) Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharm Exp Ther. 321:73–83.
   PubMed Web of Science ®Google Scholar
• Travis EL, Bucci L, Fang MZ (1990) Residual damage in mouse lungs at long intervals after cyclophosphamide treatment. Cancer Res. 50:2139–2145.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 10:1–40.
   Web of Science ®Google Scholar
• Viana M, Herrera E, Bonet B (1996) Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia. 39:1041–1046.
   PubMed Web of Science ®Google Scholar